Insider Buying: Avacta Group Plc (AVCT) Insider Buys 4,345 Shares of Stock
Avacta Group Plc (LON:AVCT) insider Michael Scott Albin bought 4,345 shares of the stock in a transaction on Tuesday, July 4th. The shares were acquired at an average cost of GBX 86 ($1.11) per share, for a total transaction of £3,736.70 ($4,840.28).
Michael Scott Albin also recently made the following trade(s):
- On Thursday, April 6th, Michael Scott Albin bought 5,731 shares of Avacta Group Plc stock. The shares were acquired at an average cost of GBX 62 ($0.80) per share, for a total transaction of £3,553.22 ($4,602.62).
Shares of Avacta Group Plc (LON AVCT) opened at 85.00 on Wednesday. The firm’s market cap is GBX 58.13 million. Avacta Group Plc has a 52 week low of GBX 60.00 and a 52 week high of GBX 110.00. The firm’s 50-day moving average is GBX 89.45 and its 200 day moving average is GBX 76.26.
Several brokerages have issued reports on AVCT. FinnCap reaffirmed a “corporate” rating and set a GBX 200 ($2.59) target price on shares of Avacta Group Plc in a research note on Tuesday, May 30th. Numis Securities Ltd reaffirmed a “buy” rating and set a GBX 160 ($2.07) target price on shares of Avacta Group Plc in a research note on Tuesday, April 4th.
About Avacta Group Plc
Avacta Group plc is a biotechnology company. Avacta’s focus is on its proprietary Affimer technology which is an engineered alternative to antibodies that has application in Life Sciences for diagnostics, therapeutics and general research and development. Affimer technology has been designed to address performance limitations of antibodies.
Receive News & Ratings for Avacta Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.